Detalhe da pesquisa
1.
A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor n-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer.
Invest New Drugs
; 40(2): 322-329, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843005
2.
Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin.
J Thromb Thrombolysis
; 50(1): 112-122, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32377957
3.
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.
Sci Rep
; 14(1): 8603, 2024 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615118
4.
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nat Commun
; 15(1): 1828, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418825
5.
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.
NPJ Precis Oncol
; 7(1): 27, 2023 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914848
6.
First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(1): 57-70, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34598945
7.
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101).
Clin Cancer Res
; 28(23): 5079-5087, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917516
8.
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors.
Cancer Discov
; 12(5): 1248-1265, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176764
9.
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Cancer Res
; 82(21): 3888-3902, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251389
10.
Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer-a narrative review.
Transl Androl Urol
; 10(10): 3931-3945, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804836
11.
Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Medicine (Baltimore)
; 100(25): e26388, 2021 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160418
12.
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer.
Lung Cancer
; 159: 162-170, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34371366
13.
Next-generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage-Multicenter experience.
Head Neck
; 42(4): 599-607, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762146
14.
Glucocorticoids as an adjunct to oncologic treatment in solid malignancies - Not an innocent bystander.
Crit Rev Oncol Hematol
; 126: 37-44, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29759565
15.
Correction: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(18): 4158, 2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106403
16.
Correction: First-in-Class Anti-Immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(8): 1734, 2022 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35419588